Renal oncocytoma screening: Difference between revisions
Shanshan Cen (talk | contribs) No edit summary |
Homa Najafi (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Renal Oncocytoma}} | {{Renal Oncocytoma}} | ||
{{CMG}}; {{AE}} {{SC}} | {{CMG}}; {{AE}}{{Homa}} {{SC}} | ||
==Overview== | ==Overview== | ||
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine [[screening]] for renal oncocytoma. | According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine [[screening]] for renal oncocytoma. | ||
| Line 7: | Line 7: | ||
==Screening== | ==Screening== | ||
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine [[screening]] for renal oncocytoma.<ref>renal oncocytoma. U.S. Preventive Service Task Force (USPSTF) 2015. http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=renal+oncocytoma Accessed on October, 27 2015 </ref> | According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine [[screening]] for renal oncocytoma.<ref>renal oncocytoma. U.S. Preventive Service Task Force (USPSTF) 2015. http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=renal+oncocytoma Accessed on October, 27 2015 </ref> | ||
==Overview== | |||
There is insufficient evidence to recommend routine screening for [disease/malignancy]. | |||
OR | |||
According to the [guideline name], screening for [disease name] is not recommended. | |||
OR | |||
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3]. | |||
==Screening== | |||
There is insufficient evidence to recommend routine screening for [disease/malignancy]. | |||
OR | |||
According to the [guideline name], screening for [disease name] is not recommended. | |||
OR | |||
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with: | |||
*[Condition 1] | |||
*[Condition 2] | |||
*[Condition 3] | |||
==References== | ==References== | ||
Revision as of 16:50, 17 April 2019
|
Renal oncocytoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Renal oncocytoma screening On the Web |
|
American Roentgen Ray Society Images of Renal oncocytoma screening |
|
Risk calculators and risk factors for Renal oncocytoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2] Shanshan Cen, M.D. [3]
Overview
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for renal oncocytoma.
Screening
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for renal oncocytoma.[1]
Overview
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
- [Condition 1]
- [Condition 2]
- [Condition 3]
References
- ↑ renal oncocytoma. U.S. Preventive Service Task Force (USPSTF) 2015. http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=renal+oncocytoma Accessed on October, 27 2015